| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8829273 | Sexual Medicine | 2016 | 8 Pages |
Abstract
LISWT in patients with ED unresponsive to PDE5i treatment was effective and safe in 60% of patients treated. The efficacy response was maintained for 12 months in most patients.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Urology
Authors
Amado MD, PhD, Adolfo MD, Walter MD, Pablo Gomez MD,